Tobramycin is an active pharmaceutical ingredient used as an aminoglycoside antibiotic. It is noted for potential developmental toxicity based on government labeling requirements.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 32986-56-4
Kanamycin
active pharmaceutical ingredient
Kanamycin acid sulfate
antibacterial active pharmaceutical ingredient
Kanamycin A sulfate
active pharmaceutical ingredient
Peramivir
neuraminidase inhibitor for influenza
Paclitaxel
active pharmaceutical ingredient
Avanafil
phosphodiesterase 5 inhibitor
Vardenafil hydrochloride trihydrate
phosphodiesterase type 5 inhibitor
4-AMINO-2-[4,6-DIAMINO-3-[3-AMINO-6-(AMINOMETHYL)-5-HYDROXYOXAN-2-YL]OXY-2-HYDROXYCYCLOHEXYL]OXY-6-(HYDROXYMETHYL)OXANE-3,5-DIOL SULFATE
active pharmaceutical ingredient
(2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol
NLVFBUXFDBBNBW-PBSUHMDJSA-N
C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N